Atlas Trials

Protocol Establishment for the Prevention of Lamotrigine-induced Skin Rash in Epilepsy Patients

Clinical trial NCT03220256 · UNKNOWN

Trial details

NCT number
NCT03220256
Sponsor
Seoul National University Hospital
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Lamotrigine Allergy
Start date
2016-08-02
Primary completion
2018-08-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.